首页 | 本学科首页   官方微博 | 高级检索  
检索        

低分子肝素治疗非ST段抬高急性冠状动脉综合征的疗效
引用本文:侯宪云,张志.低分子肝素治疗非ST段抬高急性冠状动脉综合征的疗效[J].实用医药杂志(山东),2006,23(11):1309-1310.
作者姓名:侯宪云  张志
作者单位:广州市番禺区大岗人民医院心内科,广东广州511470
摘    要:目的探讨低分子肝素对非ST段抬高急性冠状动脉综合征的疗效。方法52例非ST段抬高急性冠状动脉综合征患者在常规抗心肌缺血治疗基础上予以低分子肝素治疗。结果非ST段抬高急性冠状动脉综合征缓解率达92.3%,心电图改善率达80.8%,除4例局部注射处出现瘀斑外,余未见不良反应。结论低分子肝素对急性非ST段抬高冠状动脉综合征有较好的疗效和安全性。

关 键 词:非ST段抬高急性冠状动脉综合征  低分子量肝素
修稿时间:2006年8月18日

The efficacy observation of low-molecular weight heparins therapy for acute coronary syndrome with non-ST-segment elevation
HOU Xian-yun,ZHANG Zhi.The efficacy observation of low-molecular weight heparins therapy for acute coronary syndrome with non-ST-segment elevation[J].Practical Journal of Medicine & Pharmacy,2006,23(11):1309-1310.
Authors:HOU Xian-yun  ZHANG Zhi
Abstract:Objective To explore the effect of low-molecular weight heparins(LMWH) treating non-ST-segment elevation acute coronary syndrome (NSTEACS).Methods 52 NSTEACS cases routinely received anti -myocardial ischemia therapy in addition to LMWH. Results 92.3% of the cases responed on LMWH treatment,80.8% obtained improvement in electrocardiogram.Except 4 cases appeared ecchymosis in injection site hypodermis, others had no adverse reaction.Conclusion LMWH has better effect in safe application for treating NSTE ACS.
Keywords:Acute coronary syndrome (NSTEACS) with non-ST-segment elevation Low-molecular weight heparins (LMWH)
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号